Biomaterial Database

[Sensitivity of Mycobacterium tuberculosis to antitubercular agents]. 1979

S Levi, and H Debijadji, and M Kara-Ilić

UI	MeSH Term	Description	Entries
D009169	Mycobacterium tuberculosis	A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.	Mycobacterium tuberculosis H37Rv
D004352	Drug Resistance, Microbial	The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).	Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995	Antitubercular Agents	Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.	Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

S Levi, and H Debijadji, and M Kara-Ilić

[Biological properties of Mycobacterium tuberculosis polyresistant to antitubercular agents].

December 1984, Problemy tuberkuleza,

S Levi, and H Debijadji, and M Kara-Ilić

[Radiometric determination of Mycobacterium avium-intracellulare and Mycobacterium xenopi sensitivity to antitubercular agents].

September 1994, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne,

S Levi, and H Debijadji, and M Kara-Ilić

[Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].

January 2002, Archives de l'Institut Pasteur de Madagascar,

S Levi, and H Debijadji, and M Kara-Ilić

[Remarks on the theory of Mycobacterium tuberculosis resistance to antitubercular agents].

March 1966, Lekarska veda v zahranici,

S Levi, and H Debijadji, and M Kara-Ilić

[Surgical therapy of patients with pulmonary tuberculosis caused by Mycobacterium tuberculosis resistant to antitubercular agents].

January 1962, Problemy tuberkuleza,

S Levi, and H Debijadji, and M Kara-Ilić

[Action of synthetic antitubercular agents on the metabolism of Mycobacterium tuberculosis].

January 1987, Farmakologiia i toksikologiia,